Abstract
Background While possibility of airborne transmission in the spread of common respiratory infections, there is no consensus on the relative importance of airborne infection route in real-life. This study aimed to investigate the significance of the airborne transmissions and the effectiveness of air cleaning in reducing infections among children in daycare.
Methods A cross-over study was conducted in four daycare centers in Helsinki. All children attending the daycare were invited to participate (n = 262) and the sole inclusion criterion was that the children were expected to stay in the same day care center for the two-year duration of the study. 51 subjects were included in the final analysis. Clean air flow rate was increased by 2.1-2.9 times compared to baseline mechanical ventilation of the premises. The effect of intervention was assessed using negative binomial regression.
Results The intervention reduced incident infections from 0.95 to 0.78 infections per child per month among the children (primary outcome) in daycare. The reduction attributed to intervention in the statistical model was 18.0 % (95% CI 2.1-31.3 %, p = 0.028).
Conclusions We observed a significant decrease in incident infections without implementing any other infection mitigation strategies but air cleaning. Our results challenge the current paradigm which emphasizes fomite and contact transmission and infection control measures that target these pathways. As ventilation and air cleaning can only affect particles able to float in the air stream, our results support the significance of airborne transmission among common respiratory pathogens as well as air cleaning as an infection control measure.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT05569330
Funding Statement
The study was a part of the E3 Excellence in Pandemic Response -project funded by Business Finland [grant number 4793/31/2021], Helsinki University Hospital Coinnovation fund, Finnish Medical Foundation (VV), FLS (ES).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of Helsinki and Uusimaa gave ethical approval for this work (HUS/14231/2022)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The data will not be publicly shared due to Finnish legislation on medical research and statement of the ethics committee.
